Biological marker predicts response to immunosuppressive therapy in pediatric aplastic anemia.

Biological marker predicts response to immunosuppressive therapy in pediatric aplastic anemia. - Predicting the response IST in pediatric AA.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017972

Enrollment

400

Registered

2015-06-19

Start date

2015-06-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aplastic Anemia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acqwired aplastic anemia Less than 20 years old Informed consent from patients and/or their parents

Exclusion criteria

Exclusion criteria: Congenital aplastic anemia, including Fanconii anemia, DKC etc.

Design outcomes

Primary

Measure	Time frame
The association between each biomarker and prognosis of IST.	—

Countries

Japan

Contacts

Public ContactAtsushi Narita

Nagoya University Graduate School of Medicine Department of Pediatrics

anarita@med.nagoya-u.ac.jp052-744-2294

Outcome results